Chemotherapy-Induced Intestinal Mucosal Barrier Damage: A Cause of Falsely Elevated Serum 1,3-Beta-D-Glucan Levels?

18Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Blood citrulline and intestinal fatty acid binding protein were determined as biomarkers for intestinal mucositis. Biomarker levels were correlated with corresponding serum 1,3-beta-D-glucan levels in 56 samples obtained from 33 cases with underlying hematological malignancies receiving induction chemotherapy. No correlation between biomarkers of intestinal mucositis and BDG levels was observed. (This study has been registered at ClinicalTrials.gov under registration no. NCT01576653.).

Cite

CITATION STYLE

APA

Prattes, J., Raggam, R. B., Vanstraelen, K., Rabensteiner, J., Hoegenauer, C., Krause, R., … Hoenigl, M. (2016). Chemotherapy-Induced Intestinal Mucosal Barrier Damage: A Cause of Falsely Elevated Serum 1,3-Beta-D-Glucan Levels? Journal of Clinical Microbiology, 54(3), 798–801. https://doi.org/10.1128/JCM.02972-15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free